Adams, P. B., Lawson, S., Sanigorski, A., et al (1996) Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids, 31 (suppl. 1), 157–161.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). Washington, DC: APA.
Chang, M. C. & Jones, C. R. (1998) Chronic lithium treatment decreases brain phospholipase A2 activity. Neurochemical Research, 23, 887–892.
Cohen, J. (1988) Statistical Power Analysis for the Behavioral Sciences (2nd edn). Hillsdale, NJ: Lawrence Earlbaum.
Compton, M. T. & Nemeroff, C. B. (2000) The treatment of bipolar depression. Journal of Clinical Psychiatry, 61 (suppl. 9), 57–67.
Finnen, M. J. & Lovell, C. R. (1991) Purification and characterisation of phospholipase A2 from human epidermis. Biochemical Society Transactions, 19 (suppl), 91.
First, M. B., Spitzer, R. L., Gibbon, M., et al (1994) Structured Clinical Interview for Axis 1 DSM–IV Disorders (Patient Edn) (SCID–1/P), Version 2.0. New York: Psychiatric Research Institute.
Guy, W. (2000) Clinical Global Impression. In Handbook of Psychiatric Measures (eds Rush, A. J., Pincus, H. A., First, M. B., et al), pp. 218–222. Washington, DC: APA.
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.
Hibbeln, J. R. (1998) Fish consumption and major depression. Lancet, 351, 1213.
Horrobin, D. F. & Peet, M. (2001) Adose-ranging study of ethyl-eicosapentaenoate in treatment-unresponsive depression. Biological Psychiatry, 49 (suppl), 37.
Keck, P. E. J., Welge, J. A., McElroy, S. L., et al (2000) Placebo effect in randomized, controlled studies of acute bipolar mania and depression. Biological Psychiatry, 47, 748–755.
Kinrys, G. (2000) Hypomania associated with omega-3 fatty acids. Archives of General Psychiatry, 57, 715–716.
Macqueen, G. M., Young, L. T. & Joffe, R. T. (2001) A review of psychosocial outcome in patients with bipolar disorder. Acta Psychiatrica Scandinavica, 103, 163–170.
Nemets, B., Stahl, Z. & Belmaker, R. H. (2002) Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. American Journal of Psychiatry, 159, 477–479.
Noaghiul, S. & Hibbeln, J. R. (2003) Cross-national comparisons of seafood consumption and rates of bipolar disorder. American Journal of Psychiatry, 160, 2222–2227.
Peet, M., Horrobin, D. F. & E-E Multicentre Study Group (2002) A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. Journal of Psychiatric Research, 36, 7–18.
Puri, B. K., Counsell, S. J., Richardson, A. J., et al (2002) Eicosapentaenoic acid in treatment-resistant depression. Archives of General Psychiatry, 59, 91–92.
Seung Kim, H. F., Weeber, E. J., Sweatt, J. D., et al (2001) Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro
. Molecular Psychiatry, 6, 246–248.
Stoll, A. L. & Severus, W. E. (1996) Mood stabilizers: shared mechanisms of action at postsynaptic signal-transduction and kindling processes. Harvard Review of Psychiatry, 4, 77–89.
Stoll, A. L., Severus, W. E., Freeman, M. P., et al (1999) Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Archives of General Psychiatry, 56, 407–412.
Young, R. C., Biggs, J. T., Ziegler, V. E., et al (1978) A rating scale for mania: reliability, validity, and sensitivity. British Journal of Psychiatry, 133, 429–435.